PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
An ethyl acetate fraction of S. sinensis suppressed LPS-stimulated inflammatory mediators in RAW264.7 cells and attenuated pro-inflammatory mediators (NO, TNF-α, IL-1β, and IL-6) and liver enzymes (ALT, AST) in the serum of LPS-stimulated mice [PMID:26224027]
Certain phenanthrenes (spiranthesphenanthrenes 1 and 7) from S. sinensis exhibited moderate cytotoxic activities toward SGC-7901, HepG2, and B16-F10 cancer cell lines [PMID:31244200]
Evidence summary
PubMed sources
- 1.PMID: 35807644 (2022) — Pharmacological and Chemical Potential of Spiranthes sinensis (Orchidaceae): A Narrative Review. · Plants (Basel, Switzerland)
- 2.PMID: 29501785 (2018) — Using an integrated approach to identify cryptic species, divergence patterns and hybrid species in Asian ladies' tresses orchids (Spiranthes, Orchidaceae). · Molecular phylogenetics and evolution
- 3.PMID: 25253714 (2014) — A molecular framework for understanding the phylogeny of Spiranthes (Orchidaceae), a cosmopolitan genus with a North American center of diversity. · American journal of botany
- 4.PMID: 11141097 (2000) — Dihydrophenanthrenes from Spiranthes sinensis. · Journal of natural products
- 5.PMID: 11558594 (2001)